Literature DB >> 19200686

Determination of tropisetron in human plasma by liquid chromatography-tandem mass spectrometry.

Pan Deng1, Dafang Zhong, Xiaoyan Chen.   

Abstract

A sensitive and selective liquid chromatography-tandem mass spectrometry method (LC-MS/MS) for the determination of tropisetron in human plasma was developed and validated over the concentration range of 0.100-100 ng/mL. Diphenhydramine was used as the internal standard (IS). The tropisetron and the IS were extracted from alkalized plasma samples into diethyl ether-dichloromethane (2:1, v/v) and the LC separation was performed by a Diamonsil C18 column (150 mm x 4.6 mm, i.d., 5 microm). The mobile phase was methanol:water (80:20, v/v) containing 0.2% formic acid delivered at a flow rate of 0.5 mL/min. The total chromatographic run time was 4.5 min. The MS data acquisition was accomplished by selected reaction monitoring (SRM) mode with positive atmospheric pressure chemical ionization (APCI) interface. The lower limit of quantification (LLOQ) achieved was 0.100 ng/mL with precision (RSD) of 3.1% and accuracy (RE) of -0.7%. For both inter-batch and intra-batch tests, the precision (RSD) for the entire validation was less than 6.0%, and the accuracy (RE) was within the -0.5% to 0.2% range. This validated LC-MS/MS method was later used to characterize the pharmacokinetics as well as the bioequivalence of tropisetron formulations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200686     DOI: 10.1016/j.jpba.2008.12.038

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamics.

Authors:  Rachel Huddart; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2019-06       Impact factor: 2.089

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.